ENTYVIO

Google image searchProduct monograph

Active ingredient

vedolizumab, 108 MG/0.68 ML

DIN: 02497875

Dosage form(s): SOLUTION

Route(s) of administration: SUBCUTANEOUS

Description: SINGLE USE PRE-FILLED SYRINGE

Schedule: Prescription / Schedule D

Company: TAKEDA CANADA INC

Date: 20-NOV-2020

ATC:

• L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
• L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
• L04AG — Monoclonal antibodies (ATC, ATC/DDD)
• L04AG05 — VEDOLIZUMAB (ATC/DDD)

External Links for Entyvio

Search on Google

• Entyvio side effects
• Entyvio dosage
• vedolizumab side effects
• vedolizumab dosage

Takeda Canada Inc

Go to Takeda website to see drug product details. Sometimes you can find entyvio photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.